Progress in application of blood coagulation point-of-care testing

doi:10.3969/j.issn.1673-8640.2024.07.016

Abstract

Abstract:

Point-of-care testing （POCT） refers to the fact that it can not be limited by places，which has the advantages of easy carrying，simple operation and rapid determination. At present，the methods used in POCT blood coagulation instrument mainly include electrochemical method，biosensor method，immunochemical method and mechanical method and so on，which have their own characteristics and advantages，and they are gradually applied to blood coagulation routine test，coagulation factor determination，platelet function determination and anticoagulation monitoring. This review focuses on the principles，characteristics，application status and prospects of blood coagulation POCT technology at home and abroad.

Key words: Blood coagulation, Point-of-care testing, Technology, Application

CLC Number:

R446.11

ZHAO Chunhe, SHAO Huihui, CUI Weiqi, XIA Wei, QU Linlin. Progress in application of blood coagulation point-of-care testing[J]. Laboratory Medicine, 2024, 39(7): 709-714.

References 42

[1]	胡会利, 李宁. 电化学测量[M]. 北京: 化学工业出版社, 2020.
[2]	肖立琼, 王雷, 杨婷, 等. 心脏手术体外循环中使用i-STAT-Kaolin ACT和Medtronic ACT Ⅱ测量活化凝血时间的比较研究[J]. 国际检验医学杂志, 2020, 41(15):1831-1834.
[3]	KIM S J, LEE E Y, PARK R, et al. Comparison of prothrombin time derived from CoaguChek XS and laboratory test according to fibrinogen level[J]. J Clin Lab Anal, 2015, 29(1):28-31. DOI PMID
[4]	Corrigendum to CoaguChek^® XS versus standard laboratory prothrombin time for anticoagulant monitoring in patients with antiphospholipid syndrome[J]. Lupus, 2022, 31(5):565-574.
[5]	张明光, 宁力清. CoaguChek XS检测仪在下肢深静脉血栓形成疾病中的应用[J]. 中医临床研究, 2017, 9(12):16-17.
[6]	SHADLYN T, BAUMAN M, TANDON P, et al. Accuracy and precision of point-of-care international normalized ratio in patients with liver disease[J]. J Pediatr Gastroenterol Nutr, 2023, 76(6):704-709.
[7]	MOIZ B, RASHID A, HASAN M, et al. Prospective comparison of point-of-care device and standard analyzer for monitoring of international normalized ratio in outpatient oral anticoagulant clinic[J]. Clin Appl Thromb Hemost, 2018, 24(7):1153-1158.
[8]	KIM Y S, CHOI J W, SONG S H, et al. Comparison of the international normalized ratio between a point-of-care test and a conventional laboratory test:the latter performs better in assessing warfarin-induced changes in coagulation factors[J]. Ann Lab Med, 2023, 43(4):337-344.
[9]	王桢昌, 司士辉, 陈金华, 等. 双幅正弦波激励频移法的压电石英传感器用于测定凝血时间[J]. 传感器世界, 2023, 29(2):19-25.
[10]	CHEN J Y, PENN L S, XI J. Quartz crystal microbalance:sensing cell-substrate adhesion and beyond[J]. Biosens Bioelectron, 2018, 99:593-602.
[11]	MA Y, XIAO X, JI Q. Design of surface nanostructures for chirality sensing based on quartz crystal microbalance[J]. Beilstein J Nanotechnol, 2022, 13:1201-1219.
[12]	LIM H J, SAHA T, TEY B T, et al. Quartz crystal microbalance-based biosensors as rapid diagnostic devices for infectious diseases[J]. Biosens Bioelectron, 2020, 168:112513.
[13]	潘泓州. 基于QCM的凝血检测系统设计与实现[D]. 成都: 电子科技大学, 2022.
[14]	潘存泽. 基于QCM检测的软件系统设计与实现[D]. 成都: 电子科技大学, 2021.
[15]	BAYRAMOGLU G, OZALP C, OZTEKIN M, et al. Design of an aptamer-based magnetic adsorbent and biosensor systems for selective and sensitive separation and detection of thrombin[J]. Talanta, 2019, 191:59-66. DOI PMID
[16]	盛天宇. 基于电化学阻抗法的凝血检测仪研制[D]. 南京: 东南大学, 2021.
[17]	VRANKEN N P A, THEELEN A J A J, ORBONS T, et al. Point-of-care measurement of kaolin activated clotting time during cardiopulmonary bypass:a single sample comparison between ACT plus and i-STAT[J]. J Extra Corpor Technol, 2021, 53(1):57-61.
[18]	SCHOBER P, BOSSERS S M, KOOLWIJK J, et al. Prehospital coagulation measurement by a portable blood analyzer in a helicopter emergency medical service(HEMS)[J]. Am J Emerg Med, 2021, 46:137-140.
[19]	HARTMANN J, MURPHY M, DIAS J D. Viscoelastic hemostatic assays:moving from the laboratory to the site of care-a review of established and emerging technologies[J]. Diagnostics(Basel), 2020, 10(2):118.
[20]	ICHIKAWA Y, KAWANO K, MORI M, et al. Sonoclot's usefulness in prediction of cardiopulmonary arrest prognosis:a proof of concept study[J]. Open Med(Wars), 2022, 17(1):414-422.
[21]	万鹏, 童华生, 张兴钦, 等. Sonoclot 分析仪在重症中暑并发弥散性血管内凝血中的诊断价值[J]. 实用医学杂志, 2014(16):2562-2565.
[22]	ZHANG Z L, CHEN Y P, TAO C H, et al. Establishment of reference intervals and transfusion criterion for sonoclot analysis[J]. J Huazhong Univ Sci Technolog Med Sci, 2016, 36(4):614-617.
[23]	SACKMANN E K, FULTON A L, BEEBE D J. The present and future role of microfluidics in biomedical research[J]. Nature, 2014, 507(7491):181-189.
[24]	NEEVES K B, ONASOGA A A, WUFSUS A R. The use of microfluidics in hemostasis:clinical diagnostics and biomimetic models of vascular injury[J]. Curr Opin Hematol, 2013, 20(5):417-423.
[25]	张思祥, 竭霞, 胡雪迎, 等. 微流控电阻抗检测系统构建及其应用[J]. 分析科学学报, 2020, 36(2):295-298.
[26]	GUAN Y, ZHANG K, XU F, et al. An integrated platform for fibrinogen quantification on a microfluidic paper-based analytical device[J]. Lab Chip, 2020, 20(15):2724-2734. DOI PMID
[27]	李恬怡. 基于导电弹性体材料的血液凝固检测微流控芯片[D]. 北京: 北京化工大学, 2023.
[28]	杨志华, 罗娜, 王长奇, 等. POCT凝血分析仪电化学法检测的临床应用[J]. 实验与检验医学, 2016, 34(5):635-638.
[29]	郑安然, 张威, 郭振, 等. 活化部分凝血活酶时间检测石墨烯传感器的研制[J]. 光学精密工程, 2019, 27(6):1387-1396.
[30]	屈玲. 压电石英晶体凝血传感器检测血浆纤维蛋白原和凝血因子Ⅷ的实验研究[D]. 重庆: 第三军医大学, 2004.
[31]	VALET C, MAGNEN M, QIU L, et al. Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression[J]. J Clin Invest, 2022, 132(7):e153920.
[32]	贾媛, 白世茹, 李如意, 等. 血小板功能检测的常用方法及容易忽略的影响因素[J]. 中国心血管杂志, 2020, 25(2):197-200.
[33]	KOLTAI K, KESMARKY G, FEHER G, et al. Platelet aggregometry testing:molecular mechanisms,techniques and clinical implications[J]. Int J Mol Sci, 2017, 18(8):1803.
[34]	FRANCHINI M. The platelet function analyzer(PFA-100):an update on its clinical use[J]. Clin Lab, 2005, 51(7-8):367-372.
[35]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 抗血小板药物治疗反应多样性临床检测和处理的中国专家建议[J]. 中华心血管病杂志, 2014, 42(12):986-991.
[36]	LARDINOIS B, HARDY M, MICHAUX I, et al. Monitoring of unfractionated heparin therapy in the intensive care unit using a point-of-care aPTT:a comparative,longitudinal observational study with laboratory-based aPTT and anti-Xa activity measurement[J]. J Clin Med, 2022, 11(5):1338.
[37]	MILLING T J Jr, ZIEBELL C M. A review of oral anticoagulants,old and new,in major bleeding and the need for urgent surgery[J]. Trends Cardiovasc Med, 2020, 30(2):86-90.
[38]	RIZOS T, HERWEH C, JENETZKY E, et al. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants[J]. Stroke, 2009, 40(11):3547-3551. DOI PMID
[39]	林忠秋, 张宏亮, 丘岳, 等. 新型口服抗凝药在冠状动脉粥样硬化性心脏病中的应用研究进展[J]. 广西医学, 2022, 44(16):1920-1924.
[40]	PADAYATTIL JOSE S, BANZATO A, CARRARO P, et al. Point of care testing(POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants(NOACs)[J]. Thromb Res, 2018, 163:100-104.
[41]	HÄRTIG F, BIRSCHMANN I, PETER A, et al. Point-of-care testing of coagulation in patients treated with edoxaban[J]. J Thromb Thrombolysis, 2020, 50(3):632-639.
[42]	曹辉, 吴俊. 血凝学即时检验的临床应用[J]. 中华检验医学杂志, 2020, 43(8):837-841.